S100A8 and glioblastoma: In certain malignancies, S100A8 expression and activity were incompatible (e.g., GBM, HNSC, KICH, KIRC, KIRP, and LIHC), possibly because posttranscriptional protein modification or protein metabolism influenced S100A8 expression.